Acer therapeutics inc. (ACER)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Operating expenses:
Option Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

726

726

726

726

726

377

307

307

307

348

348

348

348

220

-

-

-

-

-

-

-

-

-

-

Research and development

2,322

2,829

2,828

4,246

3,946

5,312

2,377

2,688

2,073

1,776

2,057

1,857

3,033

3,275

-1,610

1,814

1,829

2,562

2,420

2,420

2,636

2,724

3,173

3,409

2,811

2,842

2,494

2,223

1,621

1,814

1,455

1,558

1,490

1,145

654

854

685

625

785

General and administrative

2,648

2,362

2,533

6,919

4,230

3,387

1,729

2,227

1,917

2,430

1,302

1,156

333

-275

-274

953

987

1,204

1,023

1,023

1,006

845

917

967

1,102

1,191

626

750

1,102

630

532

529

816

668

584

560

592

626

595

Total operating expenses

4,971

5,192

5,362

11,165

8,176

8,699

4,107

4,916

3,991

4,206

3,359

3,014

3,367

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-4,971

-5,192

-5,362

-11,165

-8,176

-8,699

-4,107

-4,916

-3,991

-4,206

-3,359

-3,014

-3,367

-4,314

1,885

-2,107

-2,162

-3,115

-2,807

-2,807

-3,362

-3,359

-3,880

-4,167

-3,660

-3,764

-2,863

-2,713

-2,582

-2,525

-2,069

-2,164

-2,373

-1,876

-1,296

-1,485

-1,306

-1,289

-1,429

Other income, net:
Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2

2

0

-

2

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

25

50

91

143

185

206

138

36

30

10

2

1

0

-

0

-

-

-

-

-

-

-

-

-

5

5

4

3

1

0

0

0

0

0

0

0

0

0

0

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,518

-

-

-

-

-

-

-

-

-

-

-

-

Gain on derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-136

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

120

109

12

-

0

-

-

-

-

-

-

-

-

-

-

0

346

285

1,635

198

151

0

0

0

0

0

1

2

392

Loss on disposal of asset

-

-

-

-

-

-

-

-

-

-

-0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency transaction (loss) gain

-2

-14

19

-19

23

-3

3

44

-23

-16

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income, net

22

-

110

-

208

-

141

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

65

72

76

89

89

96

96

97

98

95

77

90

88

78

78

81

76

67

52

56

70

29

37

48

Loss on disposal of asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-1

-1

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-0

-

-

-

-

Total other income, net

-

-

-

124

-

-

-

80

7

-7

-118

-108

-12

-4

0

2

2

34

11

11

11

2

0

0

0

0

0

0

37

-

-

-

-

-

-

-

-

-

-

Net loss

-4,948

-5,156

-5,251

-11,041

-7,968

-8,496

-3,965

-4,835

-3,983

-4,214

-3,478

-3,122

-3,379

-549

-1,885

-2,104

-2,160

-3,080

-2,793

-2,793

-3,350

-3,355

-3,878

-4,163

-3,655

-3,758

-5,723

-2,996

-4,177

-2,034

-2,357

-2,164

-2,373

-1,877

-1,297

-1,486

-1,307

-1,290

-1,820

Net loss per share - basic and diluted

-0.49

-0.51

-0.52

-1.09

-0.79

-0.89

-0.43

-0.64

-0.53

-0.08

-1.09

-1.29

-1.38

-1.35

-0.77

-0.30

-0.31

-0.26

-0.42

-0.42

-0.95

-2.94

-1.11

-0.15

-0.13

0.09

-0.39

-0.37

-0.58

-0.35

-0.40

-0.38

-0.41

-0.88

-0.06

-0.06

-0.06

-0.07

-0.12

Weighted average common shares outstanding - basic and diluted

10,097

10,095

10,095

10,090

10,087

10,088

9,136

7,497

7,497

6,704

3,199

2,423

2,450

-6,628

2,450

6,995

6,982

6,469

6,709

6,709

3,529

-44,814

3,478

27,661

27,584

23,377

14,721

7,991

7,239

5,855

5,762

5,762

5,762

-

23,048

23,048

-

-

-

Weighted average shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,955

18,421

15,827